The effectiveness of PD-1 inhibitors in non-small cell lung cancer (NSCLC) patients of different ages-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effectiveness of PD-1 inhibitors in non-small cell lung cancer (NSCLC) patients of different ages

Published:2017-12-26 Issue:8 Volume:9 Page:7942-7948
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wu Yingcheng¹,Ju Qianqian²³,Qian Bei¹,Zhang Feng⁴,Shi Hui³

Affiliation:

1. Medical School of Nantong University, Jiangsu 226001, China

2. Laboratory Animal Center of Nantong University, Jiangsu 226001, China

3. Department of Thoracic Surgery, Affiliated Hospital of Nantong University, Jiangsu 226001, China

4. School of Nursing, Nantong University, Jiangsu 226001, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated programmed cell death-1 protein/ligand (PD-1/PD-L1) and variants are associated with susceptibility to multiple myeloma: a case-control study in the Chinese cohort;Nucleosides, Nucleotides & Nucleic Acids;2023-09-09

2. Subtyping of advanced lung cancer based on PD-L1 expression, tumor histopathology and mutation burden (EGFR and KRAS): a study from North India;Monaldi Archives for Chest Disease;2023-02-01

3. Prognostic role of modified Glasgow Prognostic score in elderly non-small cell lung cancer patients treated with anti-PD-1 antibodies;Respiratory Investigation;2023-01

4. Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations;Therapeutic Advances in Medical Oncology;2023-01

5. The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status;OncoTargets and Therapy;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3